<DOC>
	<DOCNO>NCT01406873</DOCNO>
	<brief_summary>The purpose study investigate effect mexiletine treatment 6 month ambulation , myotonia , muscle function strength , pain , gastrointestinal functioning , cardiac conduction , quality life myotonic dystrophy type 1 ( DM1 ) .</brief_summary>
	<brief_title>Clinical Efficacy Trial Mexiletine Myotonic Dystrophy Type 1</brief_title>
	<detailed_description>This study provide data long term ( 6 month ) safety efficacy mexiletine : - improve distance participant able walk six minute ; - reduce myotonia ; - improve muscle strength ; - increase lean muscle mass ; - decreasing musculoskeletal pain ; - improve gastrointestinal function swallow ) ; - improve functional ability ; - decreasing cardiac arrhythmia ; - improve disease-specific health relate quality-of-life .</detailed_description>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<mesh_term>Mexiletine</mesh_term>
	<criteria>A diagnosis DM1 , confirm DM1 genetic mutation Ability walk 30 foot ( assistance cane and/or leg brace permit ) Presence grip myotonia Congenital DM1 Treatment Mexiletine within past 8 week Second third degree heart block , atrial flutter , atrial fibrillation , ventricular arrhythmia , receive medication treatment cardiac arrhythmia Receiving another antimyotonia drug Liver kidney disease require ongoing treatment Has seizure disorder Is pregnant lactating Had severe depression within 3 month history suicide ideation Has one follow medical condition : uncontrolled diabetes mellitus , congestive heart failure , symptomatic cardiomyopathy , symptomatic coronary artery disease , cancer ( skin cancer ) less five year previously , multiple sclerosis , serious medical illness . Drug alcohol abuse within 3 month Coexistence another neuromuscular disease Is unable give inform consent Severe arthritis medical condition ( besides DM1 ) would significantly impact ambulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Myotonic Dystrophy</keyword>
	<keyword>Myotonic Dystrophy Type 1 ( DM1 )</keyword>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Mexiletine</keyword>
</DOC>